Morgan Stanley drops one big takeaway in CVS stock earnings beat

Healthcare stocks person had a unsmooth stretch. Rising aesculapian costs, Medicaid pressure, and persistent skepticism astir managed attraction margins person kept investors connected borderline each year.

Walking into a CVS Health net study successful that situation felt similar bracing for atrocious news. The atrocious news, however, didn't come.

CVS Health (CVS) posted first-quarter 2026 adjusted EPS of $2.57, according to its net report, blowing past some Morgan Stanley's $2.17 estimation and the $2.18 statement by 40 cents.

The institution raised its full-year adjusted EPS guidance by 30 cents astatine the midpoint. And the fig that matters astir to managed attraction investors — the aesculapian payment ratio- came successful importantly amended than expected.

"With different MLR bushed successful MCO-land, we presumption the shares should grind higher connected the print," Morgan Stanley (MS) said successful a enactment shared with maine astatine TheStreet.

That is simply a measured but meaningful connection from a steadfast that has been navigating a analyzable healthcare assemblage each year.

CVS Health's Q1 2026 results bushed crossed the metrics that substance astir

The header numbers from CVS's May 6 net release:

• Total revenues of $100.4 billion, up 6.2% twelvemonth implicit year

• Adjusted EPS of $2.57, beating statement by 39 cents

• GAAP diluted EPS of $2.30

• Cash travel from operations guidance raised to astatine slightest $9.5 cardinal from $9.0 billion

• Full-year adjusted EPS guidance raised to $7.30 to $7.50 from $7.00 to $7.20
  Source: CVS Health Corporation first-quarter 2026 results net release..

The aesculapian payment ratio came successful astatine 84.6%, good beneath the Morgan Stanley estimation of 86.0% and the 86.2% consensus, according to the enactment shared.

For managed attraction investors, the MLR is the azygous astir watched fig successful immoderate quarterly people - it measures the stock of premium gross spent connected aesculapian claims. Lower is better. 84.6% is meaningfully better.

My work of that 160-basis-point bushed versus statement is that CVS's aesculapian outgo absorption held up much efficaciously than the marketplace feared heading into the quarter.

In an situation wherever peers person been struggling with elevated utilization, that is simply a genuine competitory signal.

CVS Health Services conception delivered a astonishment astir analysts didn't spot coming

Beyond the MLR, the conception that commanded the astir capitalist attraction was Health Services, CVS's pharmacy payment absorption and specialty attraction division, which has been nether unit from PBM manufacture volatility.

Health Services adjusted operating income maturation came successful astatine -7.1% twelvemonth implicit year. That sounds anemic until you comparison it to what was expected: statement was modeling antagonistic 16.7%, and Morgan Stanley's ain estimation was antagonistic 18.7%, according to the Morgan Stanley enactment shared with maine astatine TheStreet.